StockData
AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31

agilon health, inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$88.83+3.71 (+4.36%)

Close on Oct 19, 2026

Market cap
$1.53B
P/E (TTM)
–
Dividend yield
–

agilon health, inc. revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Medical services revenue$1.49B$1.42B$1.57B$1.43B$1.39B$1.53B$1.52B$1.45B$1.48B$1.60B$1.05B$1.13B99.9%+7.2%
Other operating revenue$1.82M$1.91M$2.51M$2.88M$2.94M$2.90M$3.24M$3.24M$3.18M$3.16M$2.53M$3.41M0.1%-38.1%
Other operating revenue–––––––––$3.16M–$3.53M––
Medical services revenue–––––––––$1.60B$813.34M$1.21B––

By region

From the segment and revenue-disaggregation notes of agilon health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.